Covidien and GE Healthcare Form Five-Year Collaboration
May 03 2012 - 6:00AM
Business Wire
Covidien (NYSE: COV) and GE Healthcare (NYSE: GE), leading
global providers of healthcare products and recognized innovators
in patient monitoring and respiratory care devices, today announced
a five-year, global collaboration to incorporate Covidien
measurement technologies into GE Healthcare patient monitors.
“GE Healthcare is committed to making a broad range of parameter
measurements available on our powerful monitoring technology,
including GE’s own SpO2 technology,” said Matthias Weber, General
Manager, Monitoring Solutions at GE Healthcare. “Leveraging our
100-year history of designing life-critical devices, we are focused
on delivering innovative clinical measurement technology. Such
advances have the potential to support improved care, quality, and
patient safety.”
The Nellcor™ Respiratory Function portfolio, which includes
Nellcor pulse oximetry with OxiMax™ Technology, and the BIS™ Brain
Monitoring system, are now available on many GE Healthcare patient
monitors. This includes the CARESCAPE™ Monitor B850 and CARESCAPE™
Monitor B650, which combine GE Healthcare’s strong cardiac and
anesthesiology heritage.
The Covidien collaboration reflects GE Healthcare’s commitment
to maintain an open monitoring architecture, bringing together
streams of patient data and making it usable for clinicians at the
point of care. For instance, the CARESCAPE™ Monitor B850 now
provides access to Covidien measurements, bi-directional
information flows between the monitor and hospital information
systems, such as electronic medical records, and electrocardiogram
measurements without requiring a separate monitor. Integrated
clinical information can provide valuable information for
physicians, helping guide their decisions and enhance efficiency of
care.
“The advanced parameter portfolio from Covidien, coupled with GE
Healthcare’s patient monitors, supports clinicians in detecting
subtle but critical variations in a patient’s status,” says Robert
J. White, President of Covidien Respiratory and Monitoring
Solutions. “By delivering the full picture of a patient’s
physiological status, patient safety and positive outcomes can be
advanced.”
The collaboration leverages the Covidien portfolio of patient
monitoring technologies, including:
- Nellcor pulse oximetry with OxiMax
Technology, a cardiac-based pulse oximetry platform, which
accurately monitors patients at all acuity levels and in
challenging conditions. The Nellcor pulse oximetry solution from
Covidien offers SpO2, Pulse Rate and Respiration Rate in a single
sensor design.
- INVOS™ Cerebral/Somatic Oximetry
which monitors site-specific oxygen levels to optimize end-organ
perfusion and help protect against devastating major organ
morbidity and neurological injury.
- BIS Brain Monitoring which
measures the effects of anesthetics and sedatives on the
brain.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes
and delivers value through clinical leadership and excellence.
Covidien manufactures, distributes and services a diverse range of
industry-leading product lines in three segments: Medical Devices,
Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6
billion, Covidien has 41,000 employees worldwide in more than 65
countries, and its products are sold in over 140 countries. Please
visit www.covidien.com to learn more about our business. Nellcor,
BIS, OxiMax and INVOS are trademarks of Covidien in the U.S. and
foreign countries.
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our broad
expertise in medical imaging and information technologies, medical
diagnostics, patient monitoring systems, drug discovery,
biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our
customers to deliver better care to more people around the
world at a lower cost. In addition, we partner with
healthcare leaders, striving to leverage the global policy
change necessary to implement a successful shift to
sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world
to join us on our journey as we continuously develop
innovations focused on reducing costs, increasing access and
improving quality around the world. Headquartered in the United
Kingdom, GE Healthcare is a unit of General Electric Company (NYSE:
GE). Worldwide, GE Healthcare employees are committed to
serving healthcare professionals and their patients in more than
100 countries. For more information about GE Healthcare, visit our
website at www.gehealthcare.com. CARESCAPE is a trademark of
General Electric Company.
For our latest news, please visit
http://newsroom.gehealthcare.com
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2024 to May 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From May 2023 to May 2024